Our perspectives
in one place
Topic
Selected filters
Clear
News
See allStatement at the High-Level Meeting on Universal Health Coverage
On 21 September 2023, IFPMA submitted a statement at the UN High-Level Meeting on Universal Health Coverage in New York.
Read moreStatement at the High Level Meeting on Tuberculosis
On 22 September 2023, IFPMA submitted a statement at the High-Level Meeting on Tuberculosis in New York.
Read moreStatement at the High-Level Meeting on Pandemic Prevention, Preparedness and Response
On 20 September 2023, IFPMA submitted a statement at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response in New York.
Read moreAhead of UN General Assembly, pharmaceutical industry underscores need for pandemic preparedness plans to support innovation and equity
Ahead of discussions at the United Nations General Assembly (UNGA78), the trade association representing the innovative pharmaceutical industry, the IFPMA, has warned that current pandemic preparedness plans should not undermine what worked well in response to COVID-19 and must support both “innovation and equity.”
Read more
IFPMA and Speak Up Africa announce shortlisted candidates for the 2nd edition of the Africa Young Innovators for Health Award
Read moreStatement at the 73rd Regional Committee for Africa
On 30 August, IFPMA submitted a statement at the 73rd Regional Committee for Africa in Gaborone, Botswana on the Framework for sustaining resilient health systems to achieve universal coverage and promote health security, 2023-2030 in the WHO African Region.
Read morePublications
See allAction on NCDs: How the innovative pharmaceutical industry helps bridge the care gap
In the spirit of the Global Week for Action on NCDs, this report reiterates the long-standing commitment of the innovative pharmaceutical industry to bring innovative solutions, bridge the NCDs care gap, and accelerate Universal Health Coverage (UHC) and the 2030 Sustainable Development Goals (SDGs).
Read more
IFPMA Note for Guidance on sponsorship of events and meetings (2023 update)
Collaborations between healthcare professionals (HCPs) and the pharmaceutical industry are essential and ensure that patients have access to the medicines they need and that healthcare professionals have up-to-date comprehensive information about the diseases they treat and the medicines they prescribe.
Read moreReinforcing collaboration on Universal Health Coverage to deliver greater global health equity and health security
The innovative pharmaceutical industry stands together with other members of the global health community to support countries in accelerating their efforts to achieve UHC. Read our position paper.
Read more
Expert insights
See all
Accelerating antiviral development is central to pandemic preparedness
Read more
Increasing access to medicines to support Universal Health Coverage
Read more
Decades of persistence have led to new treatments for Alzheimer’s Disease
Read moreResources
See allAction on NCDs: How the innovative pharmaceutical industry helps bridge the care gap
Read more
Navigating the ECOWAS Joint Assessment Procedure
The ECOWAS Joint Assessment Procedure is a collaborative initiative among 15 National Regulatory Agencies in West Africa that ensures harmonized and streamlined market authorization of medical products across the region. This infographic provides an overview of key steps and timelines applicants need to bear in mind during the Joint Assessment Procedure.
Read more
Advancing universal health coverage in Africa
Universal Health Coverage (UHC) is at the heart of the health-related Sustainable Development Goals (SDGs). It is the foundation for both global health security and the health and well-being of all people throughout their lifetimes. Africa’s health systems are essential in delivering the UHC2030 action agenda. Given Africa’s population is expected to double by 2050,...
Read more